Clinical trial NCT01108614 - References

HIV Infections — Injecting Drug Use Community Intervention Trial

Citation(s)

•   Ball A, Beg M, Doupe A, Weiler G
  World Health Organization, Evidence for Action for HIV Prevention, Treatment and Care among Injecting Drug Users. The International Journal of Drug Policy. 2005;16.
•   Beckett M, Burnam A, Collins RL, Kanouse DE, Beckman R
  Substance use and high-risk sex among people with HIV: a comparison across exposure groups. AIDS Behav. 2003 Jun;7(2):209-19.
•   Booth RE, Corsi KF, Mikulich-Gilbertson SK
  Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug Alcohol Depend. 2004 May 10;74(2):177-85.
•   Brady JE, Friedman SR, Cooper HL, Flom PL, Tempalski B, Gostnell K
  Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. J Urban Health. 2008 May;85(3):323-51. doi: 10.1007/s11524-007-9248-5. Epub 2008 Mar 15.
•   Costenbader EC, Astone NM, Latkin CA
  The dynamics of injection drug users' personal networks and HIV risk behaviors. Addiction. 2006 Jul;101(7):1003-13.
•   de la Fuente L, Bravo MJ, Lew C, Barrio G, Soriano V, Royuela L
  [The prevalence of human immunodeficiency virus infection and the risk behaviors in the heroin addicts of Barcelona, Madrid and Seville: an example of the advantages of centering studies on addicts and not just on intravenous users]. Med Clin (Barc). 1999 Nov 20;113(17):646-51. Spanish.
•   Des Jarlais DC, Braine N, Yi H, Turner C
  Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs. AIDS Educ Prev. 2007 Apr;19(2):111-23.
•   Des Jarlais DC, Semaan S
  HIV prevention for injecting drug users: the first 25 years and counting. Psychosom Med. 2008 Jun;70(5):606-11. doi: 10.1097/PSY.0b013e3181772157. Epub 2008 Jun 2. Review.
•   Garfein RS, Monterroso ER, Tong TC, Vlahov D, Des Jarlais DC, Selwyn P, Kerndt PR, Word C, Fernando MD, Ouellet LJ, Holmberg SD
  Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. J Urban Health. 2004 Jun;81(2):260-7.
•   Gifford E, Humphreys K
  The psychological science of addiction. Addiction. 2007 Mar;102(3):352-61.
•   Gilman SM, Galanter M, Dermatis H
  Methadone Anonymous: A 12-Step Program for Methadone Maintained Heroin Addicts. Subst Abus. 2001 Dec;22(4):247-256.
•   Gogineni A, Stein MD, Friedmann PD
  Social relationships and intravenous drug use among methadone maintenance patients. Drug Alcohol Depend. 2001 Sep 1;64(1):47-53.
•   Gossop M, Marsden J, Stewart D, Rolfe A
  Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend. 2000 Nov 1;60(3):275-86.
•   Gowing L, Farrell M, Bornemann R, Sullivan L, Ali R
  Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD004145. doi: 10.1002/14651858.CD004145.pub3. Review. Update in: Cochrane Database Syst Rev. 2011;(8):CD004145.
•   Gyarmathy VA, Neaigus A
  Marginalized and socially integrated groups of IDUs in Hungary: potential bridges of HIV infection. J Urban Health. 2005 Sep;82(3 Suppl 4):iv101-12.
•   Hartel DM, Schoenbaum EE
  Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep. 1998 Jun;113 Suppl 1:107-15.
•   International Harm Reduction Development Program of the Open Society Institute
  Saving lives by reducing harm: HIV prevention and treatment for injecting drug users. New York City, USA; 2006.
•   King VL, Kidorf MS, Stoller KB, Brooner RK
  Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment. J Addict Dis. 2000;19(4):65-83.
•   Langendam MW, van Brussel GH, Coutinho RA, van Ameijden EJ
  Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study. Addiction. 2000 Apr;95(4):591-600.
•   Lansky A, Abdul-Quader AS, Cribbin M, Hall T, Finlayson TJ, Garfein RS, Lin LS, Sullivan PS
  Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System. Public Health Rep. 2007;122 Suppl 1:48-55.
•   Latkin CA, Sherman S, Knowlton A
  HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003 Jul;22(4):332-9.
•   Lloyd JJ, Ricketts EP, Strathdee SA, Cornelius LJ, Bishai D, Huettner S, Havens JR, Latkin C
  Social contextual factors associated with entry into opiate agonist treatment among injection drug users. Am J Drug Alcohol Abuse. 2005;31(4):555-70.
•   Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J
  A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol. 2003 Mar;22(2):223-8.
•   Preston KL, Umbricht A, Epstein DH
  Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance. Arch Gen Psychiatry. 2000 Apr;57(4):395-404.
•   Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, Banys P, Hall SM
  Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA. 2000 Mar 8;283(10):1303-10.
•   Strang J, Marsden J, Cummins M, Farrell M, Finch E, Gossop M, Stewart D, Welch S
  Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome. Addiction. 2000 Nov;95(11):1631-45.
•   Termorshuizen F, Krol A, Prins M, Geskus R, van den Brink W, van Ameijden EJ
  Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users. Drug Alcohol Depend. 2005 Aug 1;79(2):231-40. Epub 2005 Feb 24.
•   Welp EA, Lodder AC, Langendam MW, Coutinho RA, van Ameijden EJ
  HIV prevalence and risk behaviour in young drug users in Amsterdam. AIDS. 2002 Jun 14;16(9):1279-84.
•   Zaric GS, Barnett PG, Brandeau ML
  HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health. 2000 Jul;90(7):1100-11.

A Randomized Community Intervention Trial on Reducing HIV Infection Among Drug Users Attending Methadone Maintenance Treatment(MMT) and Preventing Secondary Transmission From HIV Positive Clients to Their Sexual Partners in China

Details for clinical trial NCT01108614